LXR Agonist Rescues Synaptic Dysfunction and Degeneration in SPG3A Patient-Specific iPSC-Derived Neurons

By comparing SPG3A patient iPSC-derived neurons with control cells using RNA-sequencing, researchers identified synaptic dysfunction as a top-altered pathway in addition to lipid-related pathways.